Preliminary results from a phase II study of panitumumab (P) in combination with folfoxiri as first-line treatment of molecularly selected metastatic colorectal cancer (MCRC) patients (PTS)
Tumori(2011)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要